30934 Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices

active collaboration of all project

participants during the entire period of

this project.

5. Principal Investigator and Staff: (20

percent)

a. The extent to which the

qualifications and the proposed project

time allocation of the principal

investigator are described. A principal

investigator who has conducted,

evaluated, and published asthma

research in peer-reviewed journals, and

has specific authority and responsibility

to carry out the proposed project is

expected.

b. The extent to which a description

of additional staff to be assigned to this

project, their qualifications, the

proposed project time allocation, and

the role of the proposed staff is linked

to program objectives.

c. The extent to which the facilities

and other resources that would define

the applicant’s capacity to accomplish

the project are described.

6. Evaluation Plans: (15 percent)

The extent to which the applicant has

described a realistic and comprehensive

plan to accurately measure changes in

population-based asthma morbidity,

specific asthma care, asthma education

or other significant intervention

strategies over time using qualitative

and quantitative methods will be

scored. The ability of the applicant to

begin the baseline data collection during

the planning phase and to conduct a

process evaluation of the planning

period will be part of this evaluation

score.

7. Budget: (not scored)

The extent to which the budget is

clearly detailed, justified, and

appropriate for activities proposed.

I. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of:

1. Semi-annual progress reports.

2. Financial status report, no more

than 90 days after the end of the budget

period.

3. Final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR–7 Executive Order 12372 Review

AR–8 Public Health System Reporting

Requirements

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–14 Accounting System

Requirements

AR–15 Proof of Non-Profit Status

J. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

section 301 of the Public Health Service

Act, [42 U.S.C. section 241 and 247b],

as amended. The Catalog of Federal

Domestic Assistance number is 93.283.

K. Where to Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the Program

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from: Sonia

Rowell, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000, MS

E–13, Atlanta, GA 30341–4146.

Telephone number: 770–488–2724,

Email address: svp1@cdc.gov.

For program technical assistance,

contact: Michael Friedman, M.D., Air

Pollution and Respiratory Health

Branch, National Center for

Environmental Health, Centers for

Disease Control and Prevention, 1600

Clifton Road, NE., MS E–17, Atlanta,

Georgia 30333, Telephone number: 404–

639–2520, Email address: mff7@cdc.gov.

Signed: June 4, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–14447 Filed 6–7–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee to the Director,

Centers for Disease Control and

Prevention: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Advisory

Committee meeting.

Name: Advisory Committee to the Director,

CDC.

Time and Date: 8:30 a.m.–4 p.m., July 13,

2001.

Place: The Sheraton Colony Square Hotel,

188 14th Street, NE., Atlanta, Georgia 30361.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: The committee will anticipate,

identify, and propose solutions to strategic

and broad issues facing CDC.

Matters to be Discussed: Agenda items will

include updates from Dr. Jeffrey P. Koplan,

M.D., M.P.H., Director, CDC regarding the

current CDC Director’s priorities with

discussions of program activities including

updates on CDC scientific and programmatic

activities.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Kathy Cahill, Executive Secretary, Advisory

Committee to the Director, CDC, 1600 Clifton

Road, NE, M/S D–24, Atlanta, Georgia 30333.

Telephone 404/639–7060.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 4, 2001.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 01–14449 Filed 6–7–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Notice of Meeting; Office of the

Director, Centers for Disease Control

and Prevention (CDC), Announces the

Following Meeting

NAME: Guide to Community Preventive

Services (GCPS) Task Force Meeting.

Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices 30935

TIMES AND DATES: 9 a.m.–6 p.m., June 13,

2001. 9 a.m.–4 p.m., June 14, 2001.

PLACE: The Old Courthouse on the

Square, 101 East Court Square, Decatur,

Georgia 30030, telephone (404) 373–

1088.

STATUS: Open to the public, limited only

by the space available. The meeting

room accommodates approximately 50

people.

PURPOSE: The mission of the Task Force

is to develop and publish a Guide to

Community Preventive Services, which

is based on the best available scientific

evidence and current expertise

regarding essential public health

services and what works in the delivery

of those services.

MATTERS TO BE DISCUSSED: Agenda items

include: presentation of

recommendations for approval for the

following chapters: Cancer, Physical

Activity, Tobacco, Vaccine Preventive

Diseases and Violence Prevention;

presentation of the dissemination plan;

and general updates on Methods and the

Clinical Guide.

Agenda items are subject to change as

priorities dictate.

CONTACT PERSON FOR ADDITIONAL

INFORMATION: Stephanie Zaza, M.D.,

M.P.H., Chief, Community Guide

Branch, Division of Prevention Research

and Analytic Methods, Epidemiology

Program Office, CDC, 4770 Buford

Highway, M/S K–73, Atlanta, Georgia

30341, telephone 770/488–8189.

Persons interested in reserving a space

for this meeting should call 770/488–

8189 by close of business on June 11,

2001.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 4, 2001.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 01–14448 Filed 6–7–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Submission for OMB review; Comment

request

Title: Voluntary Surveys of Program

Partners to Implement Executive Order.

OMB No.: 0980–0266.

Description: Description: Under the

provisions of the Federal Paperwork

Reduction Act of 1995 (Pub. L. 104–13),

the Administration for Children and

Families (ACF) is requesting clearance

for instruments to implement Executive

Order 12862 within the ACF. The

purpose of the data collection is to

obtain customer satisfaction information

from those entities who are funded to be

our partners in the delivery of services

to the American public. ACF partners

are those entities that receive funding to

deliver services or assistance from ACF

programs. Examples of partners are

States and local governments,

territories, service providers, Indian

Tribal organizations, grantees,

researchers, or other intermediaries

serving target populations identified by

and funded directly or indirectly by

ACF. The surveys will obtain

information about how well ACF is

meeting the needs or our partners in

operating the ACF programs.

Respondents: State, Local, Tribal

Governments or Not-for Profit

institutions.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses

per respondent

Average

burden

hours per

response

Total burden hours

In-depth Interview ............................................................................................................ 476 3.16 .33 496

Estimated Total Annual Burden Hours ............................................................................ .................... .................... .................... 496

Additional Informqation: Copies of

the proposed collection may be obtained

by writing to The Administration for

Children and Families, Office of

Information Services, 370 L’Enfant

Promenade, SW., Washington, DC

20447, Attn: ACF Reports Clearance

Officer.

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following:

Office of Management and Budget,

Paperwork Reduction Project, 725 17th

Street, NW., Washington, DC 20503,

Attn: Desk Officer for ACE.

Dated: June 1, 2001.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 01–14456 Filed 6–7–01; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Endocrinologic and Metabolic Drugs

Advisory Committe; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting will be open to the

public.

Name of Committee: Endocrinologic

and Metabolic Drugs Advisory

Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on July 26 and 27, 2001, 8 a.m. to

5 p.m.

Location: Holiday Inn, Versailles

Ballrooms, 8120 Wisconsin Ave.,

Bethesda, MD.

Contact: Kathleen Reedy or LaNise

Giles, Center for Drug Evaluation and

Research (HFD–21), Food and Drug